People who undergo hormone therapy to treat prostate cancer are at higher risk of developing dementia and Alzheimer’s disease, according to a new study….
Researchers now have a clearer understanding of how the Alzheimer’s gene ApoE4 disrupts brain cells, leading to cell death and dementia symptoms. A study…
Among people with the Alzheimer’s gene, women are at greater risk of developing tau tangles, a hallmark of the disease, than men are. The…
New research suggests that the common blood pressure drug nilvadipine boosts blood flow to the brain in people with Alzheimer’s, which could potentially slow…
Advancements in genetic research now allow people to accurately track their family history and genetic risk factors. But the ubiquity of at-home DNA tests…
A common acne drug could prevent the hardening of the arteries (atherosclerosis), a condition that’s linked to heart disease and vascular dementia. Researchers at…
University of New Mexico researchers say they’ve developed a working Alzheimer’s vaccine in mice. According to the report, published in NPJ Vaccines, the team…
Was The Washington Post careless in its reporting last week that Pfizer hid information that could lead to an Alzheimer’s cure? Some members of…
In 2015, drug manufacturer Pfizer discovered that their drug Enbrel (etanercept), an anti-inflammatory used to treat rheumatoid arthritis, appeared to lower the risk of…
Tau protein tangles (or neurofibrillary tangles) are a hallmark of Alzheimer’s disease, but what role do they play? First, you need to understand how…
A new smartphone app can help people with Alzheimer’s and other forms of dementia recapture old memories via reminiscence therapy. The free app, called…
Researchers have found more evidence that Alzheimer’s may be detected through a simple blood test. The latest study published in Alzheimer’s & Dementia: The…
A study launched over two years ago using gamma light therapy to reduce beta-amyloid plaques in mice has proven to be a non-conventional treatment…
A drug designed to improve memory formation is now recruiting early-stage Alzheimer’s patients in 60 areas around the country for a Phase II clinical…
Earlier this year, the F.D.A. issued a warning to Ambrosia, a company that was selling plasma transfusions of “young blood” to elderly people, suggesting…